Definitive Contract 6913G618C100020
- Not listed
- The U.S. Department of Transportation awarded a $539,328 Small Business Innovation Research (SBIR) Phase II contract to Vox Biomedical LLC, a small business located in Bedford, Massachusetts, under Topic 17.1-NH1. The contract, awarded on September 28, 2021, with a completion date of September 27, 2023, supports the development of technology for detecting tetrahydrocannabinol (THC) use in drivers via breath analysis. This set-aside contract for small businesses represents the government's...
- This is a $239,995.27 Firm Fixed Price Definitive Contract awarded by the Department of the Navy Naval Air Systems Command Naval Air Warfare Center to Vox Biomedical LLC, a for-profit limited liability company. The contract is for a Small Business Technology Transfer (STTR) Phase I research project. The work is focused on developing innovative biomedical products using photonic technologies, with potential applications in highway and workplace safety through advanced breath analysis technology...
- The Department of Transportation awarded a $999,988.68 definitive cost-plus-fixed-fee contract to Giner Inc. of Auburndale, Massachusetts under the Small Business Innovation Research Program Phase II Topic 17.1-NH1 for research relating to the detection of tetrahydrocannabinol in drivers. The contract has a period of performance from May 5, 2021 through May 3, 2024 and is designated as a total small business set aside. Giner Inc. will conduct the research as the prime contractor to support the...
- The Department of Transportation Immediate Office of the Secretary Transportation awarded a Small Business Innovation Research (SBIR) Phase I contract to N2 Biomedical, LLC, a for-profit limited liability company, for a project titled "Driver Breath Measurement of Marijuana Intoxication by Infrared Spectroscopy". The firm-fixed-price contract, valued at $149,917.00, was set aside for small businesses and has a completion date of November 29, 2017. The SBIR Phase I contract supports...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase I contract to Charles River Analytics, Inc., a small business located in Cambridge, Massachusetts. The contract, valued at $225,000.00, is for the development of a system to specify acute tetrahydrocannabinol (THC) impairment using validated algorithms. The period of performance is from September 30, 2018 to March 30,...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Transportation (DOT) to Giner Inc., a Boston-based research and development firm. The $149,944 contract is for a project titled "Detection of THC Use in Drivers" under SBIR Topic 17.1-NH1. The contract is a firm-fixed-price definitive contract with a completion date of December 31, 2017. Giner Inc. is a for-profit organization and Subchapter S corporation that has experience providing...
- This contract was awarded by the Department of Homeland Security (DHS) Science and Technology (S&T) Directorate and Countering Weapons of Mass Destruction (CWMD) Office to Lynntech Inc., a small business, under the SBIR (Small Business Innovation Research) program. The purpose of this $149,999.88 firm fixed-price contract is to establish an award for Lynntech to develop a non-invasive breathalyzer detection system. This award is designated as a total small business set-aside. The contract...
- The Department of Homeland Security Science and Technology Directorate awarded a $149,889.69 Firm Fixed Price contract to Triton Systems, Inc., a small business based in Chelmsford, Massachusetts, under the Small Business Innovation Research (SBIR) Program. The contract is for a Phase I research and development effort to develop a non-invasive breathalyzer detection system to screen for the presence of viral respiratory infections. This award was made under a pre-solicitation for the SBIR FY21...
- This is a Phase II Small Business Innovation Research (SBIR) contract awarded by the U.S. Department of Transportation to X-Biomedical Inc., a small disadvantaged business located in Clifton Heights, Pennsylvania. The $498,901.29 fixed-price, level-of-effort contract is for the development of a "Child Presence Detection CO2 Release Test Device" under Topic 23-NH1. The contract includes a 4-month no-cost extension, with a total period of performance through January 24, 2026. This...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase II contract to Advanced Brain Monitoring, Inc., a for-profit veteran-owned manufacturer of medical devices and equipment. The contract, valued at $1,499,722.00, is for the development of a Cannabis Impairment Detection Application (CIDA) and has a period of performance from September 20, 2019, to September 19, 2021. Advanced Brain...
Vox Biomedical LLC, a small business based in Bedford, Massachusetts, was awarded a $348,957 Small Business Innovation Research (SBIR) Phase II contract by the U.S. Department of Transportation to develop technology for detecting tetrahydrocannabinol (THC) in drivers through breath analysis. The award, issued August 3, 2018, was designated as a total small business set-aside with a fixed-price, level-of-effort contract structure. The original completion date of August 3, 2020 was extended to December 3, 2020 to accommodate COVID-19 related impacts. The contract's work was to be performed at Vox Biomedical's facility in Bedford, Massachusetts. This Phase II effort builds on earlier SBIR Phase I research to advance the company's breath-based detection methodologies for roadside drug screening applications. The project aligns with the Department of Transportation's interest in developing objective, non-invasive detection methods to support highway safety initiatives. Vox Biomedical's specialized expertise in volatile organic compound analysis and portable microanalysis instrumentation positioned the company to tackle this complex analytical challenge, leveraging its existing research collaborations with academic medical centers and prior funding from the National Institutes of Health for related drug detection technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 7/31/20 | |
| P00002 | Novation Agreement | $0 | 2/14/20 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 9/10/19 | |
| Not listed | Not listed | $349.0k | 8/3/18 |